Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
First Solar Inc
NASDAQ:FSLR
|
US |
Mind Medicine (MindMed) Inc
Cash from Financing Activities
Mind Medicine (MindMed) Inc
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash from Financing Activities
$25.2m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Financing Activities
-$742m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Financing Activities
CA$269.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
21%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Cash from Financing Activities
-CA$54.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Financing Activities
-$19.9m
|
CAGR 3-Years
-90%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Financing Activities
CA$5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
Mind Medicine (MindMed) Inc
Glance View
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.
See Also
What is Mind Medicine (MindMed) Inc's Cash from Financing Activities?
Cash from Financing Activities
25.2m
USD
Based on the financial report for Sep 30, 2025, Mind Medicine (MindMed) Inc's Cash from Financing Activities amounts to 25.2m USD.
What is Mind Medicine (MindMed) Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-8%
Over the last year, the Cash from Financing Activities growth was -90%. The average annual Cash from Financing Activities growth rates for Mind Medicine (MindMed) Inc have been -25% over the past three years , -8% over the past five years .
